PYPD
PolyPid Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.88
+3.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 12.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.40x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $94.1M
- EV / sales
- —
- EV / EBITDA
- -3.17x
- EV / EBIT
- 80.87x
- Market cap
- $99.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026